{"transactions":[{"id":4613277,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-09T20:12:51.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":4564,"price":85,"value":387940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 305 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026."}],"balance_after":78532,"source":{"system":"sec-edgar","filing":"0001827584-26-000013","document":"wk-form4_1788984767.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827584/000182758426000013/wk-form4_1788984767.xml","form_type":"4"}},{"id":829436,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-24T21:05:42.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":2989,"price":66.75,"value":199515.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025."}],"balance_after":82791,"source":{"system":"sec-edgar","filing":"0001827584-26-000011","document":"wk-form4_1774386340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000011/wk-form4_1774386340.xml","form_type":"4"}},{"id":833583,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:31.000Z","date":"2026-03-19","kind":"sale","planned":false,"acquired":false,"shares":4589,"price":67,"value":307463.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":85780,"source":{"system":"sec-edgar","filing":"0001827584-26-000009","document":"wk-form4_1773961468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000009/wk-form4_1773961468.xml","form_type":"4"}},{"id":833582,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:31.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":3610,"price":68.71,"value":248043.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":90369,"source":{"system":"sec-edgar","filing":"0001827584-26-000009","document":"wk-form4_1773961468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000009/wk-form4_1773961468.xml","form_type":"4"}},{"id":833581,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:31.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":3125,"price":69.42,"value":216937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":93979,"source":{"system":"sec-edgar","filing":"0001827584-26-000009","document":"wk-form4_1773961468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000009/wk-form4_1773961468.xml","form_type":"4"}},{"id":838223,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:35:26.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":5022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."}],"balance_after":15067,"derivative":{"underlying":"Common Stock","underlying_shares":5022},"source":{"system":"sec-edgar","filing":"0001827584-26-000007","document":"wk-form4_1773779723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000007/wk-form4_1773779723.xml","form_type":"4"}},{"id":838222,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:35:26.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":16040,"derivative":{"underlying":"Common Stock","underlying_shares":8020},"source":{"system":"sec-edgar","filing":"0001827584-26-000007","document":"wk-form4_1773779723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000007/wk-form4_1773779723.xml","form_type":"4"}},{"id":838221,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:35:26.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":8148,"derivative":{"underlying":"Common Stock","underlying_shares":8148},"source":{"system":"sec-edgar","filing":"0001827584-26-000007","document":"wk-form4_1773779723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000007/wk-form4_1773779723.xml","form_type":"4"}},{"id":838220,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:35:26.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":5097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5097},"source":{"system":"sec-edgar","filing":"0001827584-26-000007","document":"wk-form4_1773779723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000007/wk-form4_1773779723.xml","form_type":"4"}},{"id":838219,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:35:26.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":26287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":97104,"source":{"system":"sec-edgar","filing":"0001827584-26-000007","document":"wk-form4_1773779723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000007/wk-form4_1773779723.xml","form_type":"4"}},{"id":853669,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-09T20:06:38.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":17161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."}],"balance_after":17161,"derivative":{"underlying":"Common Stock","underlying_shares":17161},"source":{"system":"sec-edgar","filing":"0001827584-26-000005","document":"wk-form4_1773086795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000005/wk-form4_1773086795.xml","form_type":"4"}},{"id":853668,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-09T20:06:38.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":27310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":27310,"derivative":{"exercise_price":74.9,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":27310},"source":{"system":"sec-edgar","filing":"0001827584-26-000005","document":"wk-form4_1773086795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000005/wk-form4_1773086795.xml","form_type":"4"}},{"id":858767,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:03:37.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":8366,"price":76.67,"value":641421.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025."}],"balance_after":70817,"source":{"system":"sec-edgar","filing":"0001827584-26-000002","document":"wk-form4_1772744614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758426000002/wk-form4_1772744614.xml","form_type":"4"}},{"id":963234,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-18T21:09:20.000Z","date":"2025-12-16","kind":"gift","planned":false,"acquired":true,"shares":475,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By daughter"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved the Reporting Person's gift of 475 shares of common stock to his daughter who shares Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by his daughter, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":475,"source":{"system":"sec-edgar","filing":"0001827584-25-000003","document":"wk-form4_1766092157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758425000003/wk-form4_1766092157.xml","form_type":"4"}},{"id":963233,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-18T21:09:20.000Z","date":"2025-12-16","kind":"gift","planned":false,"acquired":false,"shares":950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 451 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025."}],"balance_after":79183,"source":{"system":"sec-edgar","filing":"0001827584-25-000003","document":"wk-form4_1766092157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758425000003/wk-form4_1766092157.xml","form_type":"4"}},{"id":1195796,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:49:35.000Z","date":"2025-03-20","kind":"sale","planned":false,"acquired":false,"shares":2435,"price":50.11,"value":122017.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":79682,"source":{"system":"sec-edgar","filing":"0001819790-25-000058","document":"wk-form4_1742521768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000058/wk-form4_1742521768.xml","form_type":"4"}},{"id":1195795,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:49:35.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":2543,"price":47.4,"value":120538.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":82117,"source":{"system":"sec-edgar","filing":"0001819790-25-000058","document":"wk-form4_1742521768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000058/wk-form4_1742521768.xml","form_type":"4"}},{"id":1195794,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:49:35.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":2605,"price":46.29,"value":120585.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":84660,"source":{"system":"sec-edgar","filing":"0001819790-25-000058","document":"wk-form4_1742521768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000058/wk-form4_1742521768.xml","form_type":"4"}},{"id":1200200,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:39:14.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":24060,"derivative":{"underlying":"Common Stock","underlying_shares":8019},"source":{"system":"sec-edgar","filing":"0001819790-25-000043","document":"wk-form4_1742348347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000043/wk-form4_1742348347.xml","form_type":"4"}},{"id":1200199,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:39:14.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":16296,"derivative":{"underlying":"Common Stock","underlying_shares":8148},"source":{"system":"sec-edgar","filing":"0001819790-25-000043","document":"wk-form4_1742348347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000043/wk-form4_1742348347.xml","form_type":"4"}},{"id":1200198,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:39:14.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":5097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":5097,"derivative":{"underlying":"Common Stock","underlying_shares":5097},"source":{"system":"sec-edgar","filing":"0001819790-25-000043","document":"wk-form4_1742348347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000043/wk-form4_1742348347.xml","form_type":"4"}},{"id":1200197,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-19T01:39:14.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":21264,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,234 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2024."}],"balance_after":87265,"source":{"system":"sec-edgar","filing":"0001819790-25-000043","document":"wk-form4_1742348347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000043/wk-form4_1742348347.xml","form_type":"4"}},{"id":1217580,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-07T21:19:04.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":20089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."}],"balance_after":20089,"derivative":{"underlying":"Common Stock","underlying_shares":20089},"source":{"system":"sec-edgar","filing":"0001819790-25-000025","document":"wk-form4_1741382334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000025/wk-form4_1741382334.xml","form_type":"4"}},{"id":1217579,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T21:19:04.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":30628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option  shares shall vest on March 5, 2026, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":30628,"derivative":{"exercise_price":44.54,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":30628},"source":{"system":"sec-edgar","filing":"0001819790-25-000025","document":"wk-form4_1741382334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000025/wk-form4_1741382334.xml","form_type":"4"}},{"id":1569173,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-19T23:03:19.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":24444,"derivative":{"underlying":"Common Stock","underlying_shares":8148},"source":{"system":"sec-edgar","filing":"0001819790-24-000043","document":"wk-form4_1710889381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000043/wk-form4_1710889381.xml","form_type":"4"}},{"id":1569172,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-19T23:03:19.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":5097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":10194,"derivative":{"underlying":"Common Stock","underlying_shares":5097},"source":{"system":"sec-edgar","filing":"0001819790-24-000043","document":"wk-form4_1710889381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000043/wk-form4_1710889381.xml","form_type":"4"}},{"id":1569171,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-19T23:03:19.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":4879,"price":30.6,"value":149297.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":64767,"source":{"system":"sec-edgar","filing":"0001819790-24-000043","document":"wk-form4_1710889381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000043/wk-form4_1710889381.xml","form_type":"4"}},{"id":1569170,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-03-19T23:03:19.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":13245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,705 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023."}],"balance_after":69646,"source":{"system":"sec-edgar","filing":"0001819790-24-000043","document":"wk-form4_1710889381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000043/wk-form4_1710889381.xml","form_type":"4"}},{"id":1584371,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-11T21:10:44.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":32079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service."}],"balance_after":32079,"derivative":{"underlying":"Common Stock","underlying_shares":32079},"source":{"system":"sec-edgar","filing":"0001819790-24-000031","document":"wk-form4_1710191431.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000031/wk-form4_1710191431.xml","form_type":"4"}},{"id":1584370,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-11T21:10:44.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 7, 2025, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":47500,"derivative":{"exercise_price":35.5,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001819790-24-000031","document":"wk-form4_1710191431.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000031/wk-form4_1710191431.xml","form_type":"4"}},{"id":1940286,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:56:35.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":390,"price":12.15,"value":4738.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":54696,"source":{"system":"sec-edgar","filing":"0001827584-23-000004","document":"wf-form4_167961578319952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758423000004/wf-form4_167961578319952.xml","form_type":"4"}},{"id":1940285,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:56:35.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":379,"price":12.64,"value":4790.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":55086,"source":{"system":"sec-edgar","filing":"0001827584-23-000004","document":"wf-form4_167961578319952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758423000004/wf-form4_167961578319952.xml","form_type":"4"}},{"id":1940284,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:56:35.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":372,"price":12.89,"value":4795.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":55465,"source":{"system":"sec-edgar","filing":"0001827584-23-000004","document":"wf-form4_167961578319952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758423000004/wf-form4_167961578319952.xml","form_type":"4"}},{"id":1943215,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:12:51.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":380,"price":12.61,"value":4791.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":55837,"source":{"system":"sec-edgar","filing":"0001827584-23-000002","document":"wf-form4_167944035754056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758423000002/wf-form4_167944035754056.xml","form_type":"4"}},{"id":1943214,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:12:51.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":360,"price":13.28,"value":4780.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":56217,"source":{"system":"sec-edgar","filing":"0001827584-23-000002","document":"wf-form4_167944035754056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758423000002/wf-form4_167944035754056.xml","form_type":"4"}},{"id":1947329,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-17T22:15:59.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":5097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":15291,"derivative":{"underlying":"Common Stock","underlying_shares":5097},"source":{"system":"sec-edgar","filing":"0001209191-23-019876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019876/doc4.xml","form_type":"4"}},{"id":1947328,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:15:59.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":357,"price":13.43,"value":4794.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":56577,"source":{"system":"sec-edgar","filing":"0001209191-23-019876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019876/doc4.xml","form_type":"4"}},{"id":1947327,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:15:59.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":5097,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 862 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021, and includes 1,111 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":56934,"source":{"system":"sec-edgar","filing":"0001209191-23-019876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019876/doc4.xml","form_type":"4"}},{"id":1958977,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-11T00:26:33.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":32592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."}],"balance_after":32592,"derivative":{"underlying":"Common Stock","underlying_shares":32592},"source":{"system":"sec-edgar","filing":"0001209191-23-018001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123018001/doc4.xml","form_type":"4"}},{"id":1958976,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-11T00:26:33.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":48116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":48116,"derivative":{"exercise_price":15,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":48116},"source":{"system":"sec-edgar","filing":"0001209191-23-018001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123018001/doc4.xml","form_type":"4"}},{"id":2337817,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-11T21:17:17.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":20388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":20388,"derivative":{"underlying":"Common Stock","underlying_shares":20388},"source":{"system":"sec-edgar","filing":"0001827584-22-000002","document":"wf-form4_164703341053306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758422000002/wf-form4_164703341053306.xml","form_type":"4"}},{"id":2337816,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T21:17:17.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":69498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":69498,"derivative":{"exercise_price":19.59,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":69498},"source":{"system":"sec-edgar","filing":"0001827584-22-000002","document":"wf-form4_164703341053306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000182758422000002/wf-form4_164703341053306.xml","form_type":"4"}},{"id":2912425,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":56290,"kind":"person","name":"Neervannan Seshadri","position":1,"cik":"0001827584","reported_name":"Neervannan Seshadri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T21:57:01.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":61499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on January 7, 2022, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years."}],"balance_after":61499,"derivative":{"exercise_price":47.25,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":61499},"source":{"system":"sec-edgar","filing":"0001209191-21-002744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121002744/doc4.xml","form_type":"4"}}]}